Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.050

-8.0%

Nov 4 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (122)	12/28/1998 11:51:00 PM
From: tommysdad	Read Replies (1) of 179

oooh, I love this quote: <<"In the past few years it has become clear to me that combining database mining with rational approaches to drug design would further facilitate lead discovery.">> How pretentious is that? Are we to believe Dr. Merz thought of this first? Maybe this is why Agouron bought Alanex. Or Vertex has a combichem group. Or every big pharma in the world has both computational and combinatorial efforts going -- often on the same project.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next